BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dong-Dong L, Xi-Ran Z, Xiang-Rong C. Expression and significance of new tumor suppressor gene PTEN in primary liver cancer. J Cell Mol Med. 2003;7:67-71. [PMID: 12767263 DOI: 10.1111/j.1582-4934.2003.tb00204.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Yin LR, Chen ZX, Zhang SJ, Sun BG, Liu YD, Huang HZ. Expression of phosphatase and tensin homolog deleted on chromosome ten in liver of athymic mice with hepatocellular carcinoma and the effect of Fuzheng Jiedu Decoction. World J Gastroenterol 2008; 14(1): 108-113 [PMID: 18176971 DOI: 10.3748/wjg.14.108] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
2 Luongo F, Colonna F, Calapà F, Vitale S, Fiori ME, De Maria R. PTEN Tumor-Suppressor: The Dam of Stemness in Cancer. Cancers (Basel) 2019;11:E1076. [PMID: 31366089 DOI: 10.3390/cancers11081076] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 14.7] [Reference Citation Analysis]
3 Zhou X, Zhu H, Lu J. PTEN and hTERT gene expression and the correlation with human hepatocellular carcinoma. Pathology - Research and Practice 2015;211:316-9. [DOI: 10.1016/j.prp.2014.11.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
4 Peyrou M, Bourgoin L, Foti M. PTEN in liver diseases and cancer. World J Gastroenterol 2010; 16(37): 4627-4633 [PMID: 20872961 DOI: 10.3748/wjg.v16.i37.4627] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 47] [Article Influence: 4.7] [Reference Citation Analysis]
5 Hao LS, Zhang XL. Advances in PTEN and hepatic diseases. Shijie Huaren Xiaohua Zazhi 2008; 16(17): 1904-1911 [DOI: 10.11569/wcjd.v16.i17.1904] [Reference Citation Analysis]
6 Vinciguerra M, Carrozzino F, Peyrou M, Carlone S, Montesano R, Benelli R, Foti M. Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN. J Hepatol. 2009;50:1132-1141. [PMID: 19398230 DOI: 10.1016/j.jhep.2009.01.027] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 6.2] [Reference Citation Analysis]
7 Kim SS, Eun JW, Cho HJ, Lee H, Seo CW, Lee GH, Yoon SY, Noh CK, Cho SW, Cheong JY. Effect of PTEN Polymorphism on the Development of Hepatitis B Virus-associated Hepatocellular Carcinoma. J Liver Cancer 2019;19:46-54. [DOI: 10.17998/jlc.19.1.46] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Rountree CB, Ding W, He L, Stiles B. Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice. Stem Cells. 2009;27:290-299. [PMID: 19008348 DOI: 10.1634/stemcells.2008-0332] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 5.4] [Reference Citation Analysis]
9 Hollander MC, Blumenthal GM, Dennis PA. PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer. 2011;11:289-301. [PMID: 21430697 DOI: 10.1038/nrc3037] [Cited by in Crossref: 526] [Cited by in F6Publishing: 512] [Article Influence: 47.8] [Reference Citation Analysis]
10 Wang W, Wang Z, Chen S, Zang X, Miao J. Interleukin-1β/nuclear factor-κB signaling promotes osteosarcoma cell growth through the microRNA-181b/phosphatase and tensin homolog axis. J Cell Biochem 2019;120:1763-72. [PMID: 30977354 DOI: 10.1002/jcb.27477] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
11 Zhou J, Li X. Association of PTEN expression with liver function and inflammatory changes in patients with liver cancer after chemotherapy. Oncol Lett 2018;16:6633-7. [PMID: 30405802 DOI: 10.3892/ol.2018.9458] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Sze KM, Wong KL, Chu GK, Lee JM, Yau TO, Ng IO. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance. Hepatology 2011;53:1558-69. [PMID: 21520171 DOI: 10.1002/hep.24232] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 6.7] [Reference Citation Analysis]
13 Liu Q, Gao Y, Wang Y, Du J, Yin Q, Shi K. Diagnostic value of hepatic artery perfusion fraction combined with TGF-β in patients with hepatocellular carcinoma. Oncol Lett 2019;17:5635-41. [PMID: 31186786 DOI: 10.3892/ol.2019.10228] [Reference Citation Analysis]
14 Chen J, Liang J, Liu S, Song S, Guo W, Shen F. Differential regulation of AKT1 contributes to survival and proliferation in hepatocellular carcinoma cells by mediating Notch1 expression. Oncol Lett 2018;15:6857-64. [PMID: 29725418 DOI: 10.3892/ol.2018.8193] [Reference Citation Analysis]
15 Lah JJ, Cui W, Hu KQ. Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol 2007; 13(40): 5299-5305 [PMID: 17879397 DOI: 10.3748/wjg.v13.i40.5299] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 60] [Article Influence: 4.3] [Reference Citation Analysis]
16 Vinciguerra M, Foti M. PTEN at the crossroad of metabolic diseases and cancer in the liver. Annals of Hepatology 2008;7:192-9. [DOI: 10.1016/s1665-2681(19)31848-4] [Cited by in Crossref: 38] [Article Influence: 2.7] [Reference Citation Analysis]
17 Galicia VA, He L, Dang H, Kanel G, Vendryes C, French BA, Zeng N, Bayan JA, Ding W, Wang KS, French S, Birnbaum MJ, Rountree CB, Stiles BL. Expansion of hepatic tumor progenitor cells in Pten-null mice requires liver injury and is reversed by loss of AKT2. Gastroenterology 2010;139:2170-82. [PMID: 20837017 DOI: 10.1053/j.gastro.2010.09.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 5.5] [Reference Citation Analysis]
18 Wang H, Wu Q, Liu Z, Luo X, Fan Y, Liu Y, Zhang Y, Hua S, Fu Q, Zhao M, Chen Y, Fang W, Lv X. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma. Cell Death Dis 2014;5:e1155. [PMID: 24722280 DOI: 10.1038/cddis.2014.122] [Cited by in Crossref: 90] [Cited by in F6Publishing: 87] [Article Influence: 11.3] [Reference Citation Analysis]
19 Martin J, Dufour JF. Tumor suppressor and hepatocellular carcinoma. World J Gastroenterol 2008; 14(11): 1720-1733 [PMID: 18350603 DOI: 10.3748/wjg.14.1720] [Cited by in CrossRef: 58] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
20 Ding W, You H, Dang H, LeBlanc F, Galicia V, Lu SC, Stiles B, Rountree CB. Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion. Hepatology 2010;52:945-53. [PMID: 20564331 DOI: 10.1002/hep.23748] [Cited by in Crossref: 119] [Cited by in F6Publishing: 110] [Article Influence: 9.9] [Reference Citation Analysis]
21 Caviglia JM, Schwabe RF. Mouse models of liver cancer. Methods Mol Biol 2015;1267:165-83. [PMID: 25636469 DOI: 10.1007/978-1-4939-2297-0_8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
22 Awan FM, Naz A, Obaid A, Ikram A, Ali A, Ahmad J, Naveed AK, Janjua HA. MicroRNA pharmacogenomics based integrated model of miR-17-92 cluster in sorafenib resistant HCC cells reveals a strategy to forestall drug resistance. Sci Rep 2017;7:11448. [PMID: 28904393 DOI: 10.1038/s41598-017-11943-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
23 Sartorius K, Swadling L, An P, Makarova J, Winkler C, Chuturgoon A, Kramvis A. The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways. Viruses 2020;12:E746. [PMID: 32664401 DOI: 10.3390/v12070746] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]